Nordic Pharma Lab ApS: Financial statements 2019
CVR: 39161672
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Nordic Pharma Lab ApS (CVR 39161672) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -11,588 and a net result of DKK -11,668 compared with DKK -11,340 the year before. Equity in the 2019 report amounted to DKK 76,992. The solvency ratio was 82.6%.
- Gross Profit
- DKK -11,588
- Profit/Loss
- DKK -11,668
- Equity
- DKK 76,992
- Total Assets
- DKK 93,242
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -12 t. | -12 t. | 77 t. | - |
| 2018 | - | -11 t. | -11 t. | 89 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Nordic Pharma Lab ApS has published its annual report for 2018. Gross profit came to DKK -11,340, and the net result was DKK -11,340.
About Nordic Pharma Lab ApS
Nordic Pharma Lab ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS STM nr. 6145. The management consists of Torsten Bjørn. The company's owners include TT 1919 ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,093 and a net result of DKK -110,916 compared with DKK -30,573 the year before. Equity in the 2025 report amounted to DKK -429,426.